LNP-M/Ctrl2, scRNA-seq (Tumor)
Mus musculus
source_name
Tumor
strain
C57BL/6J
age
6–8 weeks old
tissue
Tumor
cell line
MC38-p53KO/R282W
treatment
The MC38-p53KO/R282W subcutaneous tumor model was established by inoculating MC38-p53KO/E285K cells (5 × 105 cells/mouse) subcutaneously. On day 14 post-tumor inoculation, when the tumors were palpable (~100 mm3), a single-dose treatment of LNP-M/Ctrl (40 μg/mouse) was administered intratumorally.
cell type
Immune and non-immune cells
geo_loc_name
missing
collection_date
missing